Acute bronchiolitis

Pediatric Clinics of North America

Volumn 60, Issue 5, 2013, Pages 1019-1034

  Teshome, Getachew ^a   Gattu, Rajender ^a   Brown, Reginald ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Acute bronchiolitis; Respiratory syncytial virus; Wheezing

Indexed keywords

ADRENALIN; ANTIBIOTIC AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; GLUCOCORTICOID; HELIOX; IPRATROPIUM BROMIDE; IPRATROPIUM BROMIDE PLUS SALBUTAMOL; OXYGEN; PALIVIZUMAB; PREDNISOLONE; RIBAVIRIN; SALBUTAMOL; SURFACTANT;

ACUTE DISEASE; AIRWAY OBSTRUCTION; APNEA; ASPIRATION PNEUMONIA; ASTHMA; BREATHING EXERCISE; BRONCHIOLITIS; CARDIOVASCULAR DISEASE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; COUGHING; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; FEVER; FOREIGN BODY ASPIRATION; GASTROESOPHAGEAL REFLUX; HIGH RISK POPULATION; HUMAN; IMMUNE DEFICIENCY; MEDICAL HISTORY; META ANALYSIS (TOPIC); OXYGEN NASAL CANNULA; OXYGEN THERAPY; PATHOGENESIS; PATIENT CARE; PHYSICAL EXAMINATION; PNEUMONIA; PREMATURITY; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY FAILURE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RESPIRATORY TRACT INFLAMMATION; REVIEW; RHINORRHEA; RISK ASSESSMENT; RISK FACTOR; WHEEZING; BRONCHIOLITIS, VIRAL; HUMAN RESPIRATORY SYNCYTIAL VIRUS; ISOLATION AND PURIFICATION; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;

ACUTE DISEASE; BRONCHIOLITIS; BRONCHIOLITIS, VIRAL; DIAGNOSIS, DIFFERENTIAL; HUMANS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RISK FACTORS;

EID: 84891504321     PISSN: 00313955     EISSN: 15578240     Source Type: Journal    
DOI: 10.1016/j.pcl.2013.06.005     Document Type: Review

References (88)

1. Corneli H.M., Zorc J.J., Majahan P., et al. Bronchiolitis Study Group of the Pediatric Emergency Care Applied Research Network (PECARN). A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis. NEngl J Med 2007, 357(4):331-339.
2. Stockman L.J., Curns A.T., Anderson L.J., et al. Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997-2006. Pediatr Infect Dis J 2012, 31(1):5.
3. Groothuis J., Simoes E., Hemming V. Respiratory syncytial virus (RSV) infection in preterm infants and the protective effects of RSV immune globulin (RSVIG). Pediatrics 1995, 95(4):463-467.
4. The IMpact-RSV Study Group Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998, 102(3):531-537.
5. Hall C.B., Weinberg G.A., Iwane M.K., et al. The burden of respiratory syncytial virus infection in young children. NEngl J Med 2009, 360(6):588.
6. Holman R., Shay D., Curns A., et al. Risk factors for bronchiolitis-associated deaths among infants in the United States. Pediatr Infect Dis J 2003, 22(6):483-490.
7. Johnson J.E., Gonzales R.A., Olson S.J., et al. The histopathology of fatal untreated human respiratory syncytial virus infection. Mod Pathol 2007, 20(1):108.
8. Aherne W., Bird T., Court S.D., et al. Pathological changes in virus infections of the lower respiratory tract in children. JClin Pathol 1970, 23(1):7.
9. Alverson B., Ralston S. Management of bronchiolitis: focus on hypertonic saline. Contemp Pediatr 2011, 28(2):30-38.
10. Mansbach J.M., Piedra P.A., Teach S.J., et al. MARC-30 Investigators. Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitis. Arch Pediatr Adolesc Med 2012, 166(8):700.
11. American Academy of Pediatrics Red book. Report of the Committee on Infectious Diseases. Respiratory syncytial virus 2012, 609-618. American Academy of Pediatrics, Elk Grove Village (IL).
12. Zorc J., Phelan K. What's new for seasonal wheezing: an update on the AAP's bronchiolitis guidelines and the latest evidence on assessment and treatment. Contemp Pediatr 2008, 25(2):54-62.
13. Swingler G.H., Hussey G.D., Zwarenstein M. Duration of illness in ambulatory children diagnosed with bronchiolitis. Arch Pediatr Adolesc Med 2000, 154(10):997.
14. Bacharier L., Cohen R., Schweiger T., et al. Determinants of asthma after severe respiratory syncytial virus bronchiolitis. JAllergy Clin Immunol 2012, 131(1):91-100.e3.
15. Uren E.C., Williams A.L., Jack I., et al. Association of respiratory virus infections with sudden infant death syndrome. Med J Aust 1980, 1(9):417.
16. Wang E.E., Law B.J., Stephens D. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. JPediatr 1995, 126(2):212.
17. Willson D.F., Landrigan C.P., Horn S.D., et al. Complications in infants hospitalized for bronchiolitis or respiratory syncytial virus pneumonia. JPediatr 2003, 143(Suppl 5):S142.
18. Committee on Infectious Diseases From the American Academy of Pediatrics: policy statements-modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections. Pediatrics 2009, 124(6):1694-1701.
19. Shaw K.N., Bell L.M., Sherman N.H. Outpatient assessment of infants with bronchiolitis. Am J Dis Child 1991, 145(2):151-155.
20. Chan P.W., Lok F.Y., Khatijah S.B. Risk factors for hypoxemia and respiratory failure in respiratory syncytial virus bronchiolitis. Southeast Asian J Trop Med Public Health 2002, 33(4):806-810.
21. MacDonald N.E., Hall C.B., Suffin S.C., et al. Respiratory syncytial viral infection in infants with congenital heart disease. NEngl J Med 1982, 307(7):397-400.
22. Hall C.B., Powel K.R., MacDonald N.E., et al. Respiratory syncytial viral infection in children with compromised immune function. NEngl J Med 1986, 315(2):77-81.
23. Viswanathan M., King V.J., Bordley C., et al. Management of bronchiolitis in infants and children. Evid Rep Technol Assess (Summ) 2003, (69):1-5.
24. Lowell D.I., Lister G., Von Koss H., et al. Wheezing in infants: the response to epinephrine. Pediatrics 1987, 79(6):939-945.
25. Brooks A.M., McBride J.T., McConnochie K.M., et al. Predicting deterioration in previously healthy infants hospitalized with respiratory syncytial virus infection. Pediatrics 1999, 104(3 Pt 1):463-467.
26. Schroeder A.R., Marmor A.K., Pantell R.H., et al. Impact of pulse oximetry and oxygen therapy on length of stay in bronchiolitis hospitalizations. Arch Pediatr Adolesc Med 2004, 158(6):527-530.
27. Laham F.R., Troll A.A., Bennett B.L., et al. LDH concentration in nasal-wash fluid as a biochemical predictor of bronchiolitis severity. Pediatrics 2010, 125(2):e225-e233.
28. Kuppermann N., Bank D.E., Walton E.A., et al. Risks for bacteremia and urinary tract infections in young febrile children with bronchiolitis. Arch Pediatr Adolesc Med 1997, 151(12):1207-1214.
29. Levine D.A., Platt S.L., Dayan P.S., et al. Risk of serious bacterial infection in young febrile infants with respiratory syncytial virus infections. Pediatrics 2004, 113(6):1728-1734.
30. Carsin A., Gorincour G., Bresson V., et al. Chest radiographs in infants hospitalized for acute bronchiolitis: real information or just irradiation?. Arch Pediatr 2012, 19(12):1308-1315. [in French]. 10.1016/j.arcped.2012.09.019.
31. Bordley W.C., Viswanthan M., King V.J., et al. Diagnosis and testing in bronchiolitis: a systematic review. Arch Pediatr Adolesc Med 2004, 158(2):119-126.
32. American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis Diagnosis and management of bronchiolitis. Pediatrics 2006, 118(4):1774-1793.
33. Harris J.A., Huskins W.C., Langley J.M., Pediatric Special Interest Group of the Society for Healthcare Epidemiology of America, et al. Health care epidemiology perspective on the October 2006 recommendations of the Subcommittee on Diagnosis and Management of Bronchiolitis. Pediatrics 2007, 120(4):890-892.
34. Smyth R.L., Openshaw P.J. Bronchiolitis. Lancet 2006, 368:312.
35. Vogel A.M., Lennon D.R., Harding J.E., et al. Variations in bronchiolitis management between five New Zealand hospitals: can we do better?. JPaediatr Child Health 2003, 39:40.
36. Adcock P.M., Stout G.G., Hauck M.A., et al. Effect of rapid viral diagnosis on the management of children hospitalized with lower respiratory tract infection. Pediatr Infect Dis J 1997, 16:842.
37. Krilov L.R., Lipson S.M., Barone S.R., et al. Evaluation of a rapid diagnostic test for respiratory syncytial virus (RSV): potential for bedside diagnosis. Pediatrics 1994, 93(6 Pt 1):903-906.
38. Van Steensel-Moll H.A., Hazelzet J.A., van der Voort E., et al. Excessive secretion of antidiuretic hormone in infections with respiratory syncytial virus. Arch Dis Child 1990, 65(11):1237-1239.
39. Kuzik B.A., Al-Qadhi S.A., Kent S., et al. Nebulized hypertonic saline in the treatment of viral bronchiolitis in infants. JPediatr 2007, 151(3):266-270. 270.e1.
40. Willson D.F., Horn S.D., Hendley J.O., et al. Effect of practice variation on resource utilization in infants for viral lower respiratory illness. Pediatrics 2001, 108:851-855.
41. Wang E.E., Law B.J., Boucher F.D., et al. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of admission and management variation in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. JPediatr 1996, 129:390-395.
42. Brand P.L., Vaessen-Verberne A.A. Differences in management of bronchiolitis between hospitals in the Netherlands. Eur J Pediatr 2000, 159:343-347.
43. Alario A.J., Lewander W.J., Dennehy P., et al. The efficacy of nebulized metaproterenol in wheezing infants and young children. Am J Dis Child 1992, 146:412-418.
44. Henry R.L., Milner A.D., Stokes G.M. Ineffectiveness of ipratropium bromide in acute bronchiolitis. Arch Dis Child 1983, 58:925-926.
45. Klassen T.P., Rowe P.C., Sutcliffe T., et al. Randomized trial of salbutamol in acute bronchiolitis. JPediatr 1991, 118:807-811.
46. Lines D.R., Kattampallil J.S., Liston P. Efficacy of nebulized salbutamol in bronchiolitis. Pediatr Rev Commun 1990, 5:121-129.
47. Mallol J., Barrueo L., Girardi G., et al. Use of nebulized bronchodilators in infants under 1 year of age: analysis of four forms of therapy. Pediatr Pulmonol 1987, 3:298-303.
48. Tal A., Bavilski C., Yohai D., et al. Dexamethasone and salbutamol in the treatment of acute wheezing in infants. Pediatrics 1983, 71:13-18.
49. Schweich P.J., Hurt T.L., Walkley E.I., et al. The use of nebulized albuterol in wheezing infants. Pediatr Emerg Care 1992, 8:184-188.
50. Schuh S., Canny G., Reisman J.J., et al. Nebulized albuterol in acute bronchiolitis. JPediatr 1990, 117:633-637.
51. Dobson J.V., Stephens-Groff S.M., McMahon S.R., et al. The use of albuterol in hospitalized infants with bronchiolitis. Pediatrics 1998, 101:361-368.
52. Flores G., Horwitz R.I. Efficacy of beta2-agonists in bronchiolitis: a reappraisal and meta-analysis. Pediatrics 1997, 100:233-239.
53. Kristjansson S., Lodrup Carlsen K.C., Wennergren G., et al. Nebulised racemic adrenaline in the treatment of acute bronchiolitis in infants and toddlers. Arch Dis Child 1993, 69:650-654.
54. Behrendt C.E., Decker M.D., Burch D.J., et al. International variation in the management of infants hospitalized with respiratory syncytial virus. International RSV Study Group. Eur J Pediatr 1998, 157:215-220.
55. Shay D.K., Holman R.C., Newman R.D., et al. Bronchiolitis associated hospitalizations among US children, 1980-1996. JAMA 1999, 282:1440-1446.
56. Fernandes R.M., Bialy L.M., Vandermeer B., et al. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev 2010, (10). CD004878.
57. Davison C., Ventre K.M., Luchetti M., et al. Efficacy of interventions for bronchiolitis in critically ill infants: a systematic review and meta-analysis. Pediatr Crit Care Med 2004, 5(5):482-489.
58. Putto A., Ruuskanen O., Meruman O. Fever in respiratory virus infections. Am J Dis Child 1986, 140:1159-1163.
59. LaVia W., Marks M.I., Stutman H.R. Respiratory syncytial virus puzzle: clinical features, pathophysiology, treatment, and prevention. JPediatr 1992, 121:503-510.
60. Nichol K.P., Cherry J.D. Bacterial-viral interrelations in respiratory infections in children. NEngl J Med 1967, 277:667-672.
61. Hall C.B., Powell K.R., Schnabel K.C., et al. Risk of serious bacterial infection in infants hospitalized with respiratory syncytial viral infection. JPediatr 1988, 113:266-271.
62. Purcell K., Fergie J. Concurrent serious bacterial infections in 2396 infants and children hospitalized with respiratory syncytial virus lower respiratory tract infections. Arch Pediatr Adolesc Med 2002, 156:322-324.
63. Krilov L.R., Mandel F.S., Baron S.R., et al. Follow-up of children with respiratory syncytial virus bronchiolitis in 1986 and 1987: potential effect of ribavirin on long term pulmonary function. Pediatr Infect Dis J 1997, 16(3):273-276.
64. Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections. American Academy of Pediatrics Committee on Infectious Diseases. Pediatrics 1996, 97(1):137-140.
65. Ventre K., Randolph A.G. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children. Cochrane Database Syst Rev 2007, (1). CD000181.
66. Randolph A.G., Wang E.E. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract. Cochrane Database Syst Rev 2000, (2). CD000181.
67. Bradley J.S., Conner J.D., Compagiannis L.S., et al. Exposure of health care workers to ribavirin during therapy for respiratory syncytial virus infections. Antimicrobial Agents Chemother 1990, 34:668-670.
68. Rodriguez W.J., Bui R.H.D., Conner J.D., et al. Environmental exposure of primary care personnel to ribavirin aerosol when supervising treatment of infants with respiratory syncytial virus infections. Antimicrobial Agents Chemother 1987, 31:1143-1146.
69. Feldstein T.J., Swegarden J.L., Atwood G.F., et al. Ribavirin therapy: implementation of hospital guidelines and effect on usage and cost of therapy. Pediatrics 1995, 96:14-17.
70. Liet J.M., Millotte B., Tucci M., et al. Canadian Critical Care Trials Group. Noninvasive therapy with helium-oxygen for severe bronchiolitis. JPediatr 2005, 147(6):812-817.
71. Martinón-Torres F., Rodríguez-Núñez A., Martinón-Sánchez J.M. Heliox therapy in infants with acute bronchiolitis. Pediatrics 2002, 109(1):68-73.
72. Hollman G., Shen G., Zeng L., et al. Helium-oxygen improves clinical asthma scores in children with acute bronchiolitis. Crit Care Med 1998, 26(10):1731-1736.
73. Cambonie G., Milési C., Fournier-Favre S., et al. Clinical effects of heliox administration for acute bronchiolitis in young infants. Chest 2006, 129(3):676-682.
74. Liet J.M., Ducruet T., Gupta V., et al. Heliox inhalation therapy for bronchiolitis in infants. Cochrane Database Syst Rev 2010, (4). CD006915.
75. Weinberger M.M. High-dose systemic corticosteroids may be effective early in the course of bronchiolitis. Pediatrics 2007, 119(4):864-865. [discussion: 865-6].
76. King V.J., Viswanathan M., Bordley W.C., et al. Pharmacologic treatment of bronchiolitis in infants and children: a systematic review. Arch Pediatr Adolesc Med 2004, 158(2):127-137.
77. Cade A., Brownlee K.G., Conway S.P., et al. Randomised placebo controlled trial of nebulised corticosteroids in acute respiratory syncytial viral bronchiolitis. Arch Dis Child 2000, 82(2):126-130.
78. Blom D., Ermers M., Bont L., et al. Inhaled corticosteroids during acute bronchiolitis in the prevention of post-bronchiolitic wheezing. Cochrane Database Syst Rev 2007, (1). CD004881.
79. Jat K.R., Chawla D. Surfactant therapy for bronchiolitis in critically ill infants. Cochrane Database Syst Rev 2012, (9). CD009194.
80. LeVine A.M., Elliott J., Whitsett J.A., et al. Surfactant protein-d enhances phagocytosis and pulmonary clearance of respiratory syncytial virus. Am J Respir Cell Mol Biol 2004, 31(2):193-199.
81. Tibby S.M., Hatherill M., Wright S.M., et al. Exogenous surfactant supplementation in infants with respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 2000, 162(4 Pt 1):1251-1256.
82. Prendiville A., Green S., Silverman M. Ipratropium bromide and airways function in wheezy infants. Arch Dis Child 1987, 62(4):397-400.
83. Panickar J., Lakhanpaul M., Lambert P.C., et al. Oral prednisolone for preschool children with acute virus-induced wheezing. NEngl J Med 2009, 360(4):329-338.
84. Kim I.K., Phrampus E., Sikes K., et al. Helium-oxygen therapy for infants with bronchiolitis: a randomized controlled trial. Arch Pediatr Adolesc Med 2011, 165(12):1115-1122.
85. Plint A.C., Johnson D.W., Patel H., et al. Pediatric Emergency Research Canada (PERC). Epinephrine and dexamethasone in children with bronchiolitis. NEngl J Med 2009, 360(20):2079-2089.
86. Perrotta C., Ortiz Z., Roque M. Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old. Cochrane Database Syst Rev 2007, (1). CD004873.
87. Al-Ansari K., Sakran M., Davidson B., et al. Nebulized 5% or 3% hypertonic or 0.9% saline for treating acute bronchiolitis in infants. JPediatr 2010, 157(4):630-634.
88. McKiernan C., Chua L.C., Visintainer P.F., et al. High flow nasal cannulae therapy in infants with bronchiolitis. JPediatr 2010, 156(4):634.